Calamos Advisors »

Augmedix shares owned by Calamos Advisors

Quarter-by-quarter ownership of Augmedix (AUGX) shares owned by Calamos Advisors from 13F filings

Historical chart of Calamos Advisors investment in Augmedix

Tip: Access up to 7 years of quarterly data

All positions including Augmedix held by Calamos Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Augmedix by Calamos Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $886k 152k 5.85

More positions owned by Calamos Advisors

Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Alphabet Cap Stk Cl A (GOOGL)
Palo Alto Networks Note 0.375% 6/0 (Principal)
Meta Platforms Cl A (META)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Eli Lilly & Co. (LLY)
Pioneer Nat Res Note 0.250% 5/1 (Principal)
UnitedHealth (UNH)
Visa Com Cl A (V)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)

View all positions for Calamos Advisors

Top funds holding Augmedix

Redmile Group
Samjo Management
Divisadero Street Capital Management
Perkins Capital Management
Vanguard Group
Caption Management
Russell Investments
G2 Investment Partners Management
American Financial Group
Balyasny Asset Management
Essex Investment Management
Kennedy Capital Management
Millennium Management
Point72 Asset Management
Resolute Capital Asset Partners

View all funds holding Augmedix